These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9448099)

  • 1. Anti-proliferative effect of toremifene and tamoxifen on estrogen receptor-lacking anaplastic thyroid carcinoma cell lines.
    Kishino T; Watanabe M; Kimura M; Sugawara I
    Biol Pharm Bull; 1997 Dec; 20(12):1257-60. PubMed ID: 9448099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
    Boylan M; van den Berg HW; Lynch M
    Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative properties of toremifene on AIDS-related Kaposi's sarcoma cells.
    Hong A; Leigh BR
    Chemotherapy; 2002 Dec; 48(5):238-43. PubMed ID: 12476040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen antagonizes proliferation and invasion of estrogen receptor-negative metastatic follicular thyroid cancer cells via protein kinase C.
    Hoelting T; Duh QY; Clark OH; Herfarth C
    Cancer Lett; 1996 Feb; 100(1-2):89-93. PubMed ID: 8620458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiestrogen stimulated human endometrial cancer growth: laboratory and clinical considerations.
    Tonetti DA; O'Regan R; Tanjore S; England G; Jordan VC
    J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):181-9. PubMed ID: 9699872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toremifene resistance in a rat mammary tumour model.
    Kellen JA; Georges E; Ling V; Dubsky M
    Anticancer Res; 1992; 12(5):1663-5. PubMed ID: 1359832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
    Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
    Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The diverse effects of hormonal therapeutic agents on the proliferations of human breast cancer cell lines, MCF-7 and its variants].
    Aoyagi H
    Nihon Naibunpi Gakkai Zasshi; 1995 Jan; 71(1):39-52. PubMed ID: 7895864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth inhibitory effects of flavonoids in human thyroid cancer cell lines.
    Yin F; Giuliano AE; Van Herle AJ
    Thyroid; 1999 Apr; 9(4):369-76. PubMed ID: 10319943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of the effects of tamoxifen, toremifene and raloxifene on enzyme induction and gene expression in the ovariectomised rat uterus.
    Green AR; Parrott EL; Butterworth M; Jones PS; Greaves P; White IN
    J Endocrinol; 2001 Sep; 170(3):555-64. PubMed ID: 11524235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compartmentalized uterotrophic effects of tamoxifen, toremifene, and estradiol in the ovariectomized Wistar (Han) rat.
    Carthew P; Edwards RE; Nolan BM; Tucker MJ; Smith LL
    Toxicol Sci; 1999 Apr; 48(2):197-205. PubMed ID: 10353311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and pharmacological effects of toremifene metabolites.
    Kangas L
    Cancer Chemother Pharmacol; 1990; 27(1):8-12. PubMed ID: 2147128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety assessment of tamoxifen and toremifene.
    Williams GM; Jeffrey AM
    Oncology (Williston Park); 1997 May; 11(5 Suppl 4):41-7. PubMed ID: 9165506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bioassay for antiestrogenic activity--potential utility in drug development and monitoring effective in vivo dosing.
    DeGregorio M; Wurz G; Emshoff V; Koester S; Minor P; Wiebe V
    Breast Cancer Res Treat; 1992; 24(1):35-41. PubMed ID: 1463870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women.
    Marttunen MB; Cacciatore B; Hietanen P; Pyrhönen S; Tiitinen A; Wahlström T; Ylikorkala O
    Br J Cancer; 2001 Apr; 84(7):897-902. PubMed ID: 11286468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen inhibits hepatoma cell growth through an estrogen receptor independent mechanism.
    Jiang SY; Shyu RY; Yeh MY; Jordan VC
    J Hepatol; 1995 Dec; 23(6):712-9. PubMed ID: 8750171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiestrogenic tamoxifen and toremifene increase serum leptin levels in postmenopausal breast cancer patients.
    Marttunen MB; Andersson S; Hietanen P; Karonen SL; Koistinen HA; Koivisto VA; Tiitinen A; Ylikorkala O
    Maturitas; 2000 May; 35(2):175-9. PubMed ID: 10924844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells].
    Zhang YH; Li G; Yu J; Xu MS; Liu ZX
    Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):654-60. PubMed ID: 22340044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptors in human myeloma cells.
    Otsuki T; Yamada O; Kurebayashi J; Moriya T; Sakaguchi H; Kunisue H; Yata K; Uno M; Yawata Y; Ueki A
    Cancer Res; 2000 Mar; 60(5):1434-41. PubMed ID: 10728710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective reversal of vinblastine resistance in multidrug-resistant cell lines by tamoxifen, toremifene and their metabolites.
    Kirk J; Houlbrook S; Stuart NS; Stratford IJ; Harris AL; Carmichael J
    Eur J Cancer; 1993; 29A(8):1152-7. PubMed ID: 8518026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.